Mei Ri Jing Ji Xin Wen·2025-11-14 06:59Group 1 - The Hong Kong stock market experienced a decline, with the Hang Seng Technology Index dropping over 2%, while internet healthcare stocks rose against the trend [1] - JD Health reported a revenue of 17.12 billion yuan for Q3 2025, marking a year-on-year increase of 28.7%, and an operating profit of 1.243 billion yuan, up 125.3% year-on-year [1] - JD Health signed strategic cooperation agreements with major pharmaceutical companies such as Eli Lilly, Innovent Biologics, Eisai China, and Bayer China [1] Group 2 - The online pharmacy sales share of retail pharmacy terminals increased from 3.2% in 2015 to 32.5% in 2023, driven by factors such as lower prices, a wide variety of products, and improved consumer purchasing habits [2] - Regulatory policies for online pharmaceutical sales have gradually relaxed since 2022, allowing prescription drugs to be purchased online with real-name verification [2]